Dexmedetomidine Sublingual Film for Autonomic Crises in Familial Dysautonomia
Official title: Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients with Familial Dysautonomia
Funded at New York University School of Medicine · NIH-11177687 · Data updated 2026-11-12
This project looks at using a sublingual film medication to help people with familial dysautonomia manage sudden, severe changes in blood pressure and heart rate at home.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 15, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $377,195 |
| NIH project number | 5R01FD007826-03 |
| Project ID | NIH-11177687 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are patients diagnosed with familial dysautonomia who experience frequent hyperadrenergic autonomic crises.
✕Less likely to help
Patients without familial dysautonomia or those who do not experience hyperadrenergic autonomic crises would not directly benefit from this specific treatment approach.
What this research studies
Familial dysautonomia (FD) is a rare genetic condition that causes many health challenges, including frequent and severe episodes called hyperadrenergic autonomic crises. These crises involve a sudden spike in blood pressure and heart rate, often with vomiting, and can be dangerous. Current home treatments can have serious side effects like sedation or respiratory problems. This project aims to find a safer and more effective way to manage these crises at home by exploring a sublingual film containing dexmedetomidine, a medication that could help calm the body's overactive stress response during these episodes.
Why it matters
Potential benefit: If successful, this new treatment could provide a safer and more effective way for patients with familial dysautonomia to manage severe autonomic crises at home, potentially preventing serious complications.
How similar studies have gone: This project proposes a novel approach to treating these crises, indicating that current methods are insufficient and this specific drug delivery for this condition is largely untested.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Gonzalez-Duarte Briseno, Maria Alejandra — New York University School of Medicine
- Study coordinator: Gonzalez-Duarte Briseno, Maria Alejandra
Related research
Other NIH-funded projects on the same topics.
-
Naloxone-DEXmedetomidine combo to calm methamphetamine agitation in polysubstance use
A study at Marshall University tests whether a naloxone and dexmedetomidine combination can safely and effectively reduce agitation in people acutely intoxicated with methamphetamine and other substances.
-
Dexmedetomidine Sublingual Film for Flare-Ups in Familial Dysautonomia
A new dexmedetomidine pill under the tongue is being tested to help people with familial dysautonomia manage sudden sympathetic flare-ups at home.
-
Preventing Confusion After Heart Surgery with a Special Sleep Medication
This project looks at whether a medication called dexmedetomidine can help prevent confusion and memory problems in older patients after heart surgery.
-
New treatment for severe autonomic crises in patients with familial dysautonomia
This study is looking at a new way to help people with familial dysautonomia manage sudden, severe symptoms using a special film that dissolves under the tongue, which could make it easier and safer for them to handle these episodes at home.
-
Using low doses of dexmedetomidine to treat respiratory failure from fentanyl overdose
This study is looking at how a small amount of a brain medication called dexmedetomidine can help people breathe normally again after they've had trouble breathing from a fentanyl overdose.
-
Using a new medication to help treat opioid withdrawal symptoms
This study is looking at a new film you place under your tongue that contains a medication called dexmedetomidine to help ease withdrawal symptoms for people dealing with opioid use disorder, especially those using strong opioids like fentanyl, and it aims to find out if this treatment is safe and works better than cur
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.